Indications
Vasculitis
Mycophenolate Mofetil in combination with corticosteroids and either ciclosporin or tacrolimus is indicated for-
Prophylaxis of acute organ rejection and treatment of first or refractory organ rejection in patients receiving allogeneic renal transplants.
Prophylaxis of acute organ rejection in patients receiving allogeneic cardiac transplants.
... Read more
Mycophenolate Mofetil in combination with corticosteroids and either ciclosporin or tacrolimus is indicated for-
Prophylaxis of acute organ rejection and treatment of first or refractory organ rejection in patients receiving allogeneic renal transplants.
Prophylaxis of acute organ rejection in patients receiving allogeneic cardiac transplants.
Prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants.
Mycophenolate Mofetil is indicated for induction and maintenance therapy of patients with Class III-V lupus nephritis (diagnosed according to International Society of Nephrology/Renal Pathology Society classification.
Dosage And Administration
Transplant patients:
Standard dosage for prophylaxis of renal rejection
Adults: A dose of 1 g administered orally twice a day (daily dose of 2 g) is recommended for use in renal transplant patients.
Children (aged 3 months to 18 years): Patients with a body surface area of 1.25 to 1.5 m2 may be prescribed Mycophenolate Mofetil Tablets at a dose of 750 mg twice daily (1.5 g daily dose). Patients with a body surface area >1.5 m2 may be prescribed Mycophenolate Mofetil tablets at a dose of 1 gm twice daily (2 g daily dose).
Standard dosage for prophylaxis of cardiac rejection-
Adults: A dose of 1.5 g administered orally (over not less than 2 hour) twice a day (daily dose of 3 g) is recommended for use in cardiac transplant patients.
Children: no data are available for pediatric cardiac transplant patients.
Standard dosage for prophylaxis of hepatic rejection-
Adults: A dose of 1.5 g orally twice a day (daily dose of 3 g) is recommended for use in hepatic transplant patients
Children: no data are available for pediatric hepatic transplant patients.
Standard dosage for treatment of first or refractory renal rejection-
Adults: A dose of 1.5 g administered orally twice a day (daily dose of 3 g) is recommended for management of first or refractory rejection.
Children: no data are available for the treatment of first or refractory renal rejection in pediatric renal transplant patients.
Lupus nephritis patients:
Standard Dosage for Induction Therapy-
Adults: A dose of 750 mg-1.5 g administered orally twice a day (daily dose of up to 3 g) is recommended
Children: A dose of 600 mg/m2 administered orally twice a day (up to a maximum of 2 g daily) is recommended
Standard Dosage for Maintenance Therapy-
Adults: A dose of 500 mg-1 g administered orally twice a day is recommended
Children: A dose of 300 mg/m2 administered orally twice a day is recommended
Mycophenolate Mofetil should be used in combination with corticosteroids. Doses should be introduced gradually and adjusted according to clinical response. Therapeutic drug monitoring could help prevent sub-therapeutic exposure (Cmin≥3.0 mg/L or inter-dose AUC ≥35 h*mg/L).
Side Effects
The principal adverse reactions associated with the administration of Mycophenolate Mofetil includes diarrhea, leukopenia, sepsis, gastrointestinal candidiasis, urinary tract infection, herpes simplex, vomiting and there is evidence of a higher frequency of certain types of infections eg. opportunistic infections.
Precautions And Warnings
Mycophenolic acid tablets are used with caution because it-
Can increase new or reactive viral infections. Such infections include latent viral reactivation, such as hepatitis B or hepatitis C reactivation, or infections caused by polyomaviruses.
Can cause blood dyscrasias including pure red cell aplasia (PRCA).
Can cause serious GI tract complications (gastrointestinal bleeding, perforations and ulcers).
May increase the risk of developing lymphomas and other malignancies, particularly of the skin.
Use of live vaccines should be avoided during treatment with Mycophenolic acid.
Patients should not donate blood during therapy.
Pregnancy And Lactation
Mycophenolate Mofetil is contraindicated in pregnancy and during breastfeeding. The safe use of Mycophenolate Mofetil during labor and delivery has not been established.